Irina Haivas, recently promoted to Partner at Atomico, has a big vision for the future of biology ... [+] and European startups. But laying out a manifesto isn’t just about announcing a VC call for so-called Biology 2.0 startups; Haivas has bigger ideas about how to inject enthusiasm, investment and bigger thinking into the European biotech sector. The challenge for Biology 2.0 startups though, is that this distribution doesn’t always make for a united enthusiasm and understanding around their potential opportunity. “It’s not that trivial.”Her choice of wording: “Biology 2.0”, does seem to take the “biotech” term and separate it from the Silicon Roundabout crowd. Instead of it being another vertical duly named by crudely gluing “tech” onto half an industry (“fintech,” “insurtech,” “proptech”), Biology 2.0 has an air of seriousness and conviction.

Source: Forbes January 16, 2020 08:29 UTC